Status
Conditions
Treatments
About
Gluten free diet (GFD) is now being tested in patients affected by schizophrenia, autism and multiple sclerosis, making GFD a possible therapeutic weapon not only for celiac disease or gluten sensitivity. In this protocol we investigate the effect of GFD in patients affected by burning mouth syndrome (BMS), a disease of unknown origin characterized by oral and especially tongue burning sensation, deeply decreasing the quality of life of patients
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
-Primary BMS
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
40 participants in 2 patient groups
Loading...
Central trial contact
Luca Elli, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal